XTX Topco’s KALA BIO KALA Stock Holding History

XTX Topco’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-566	Closed	-$15.7K	–	4093
2025 Q4	$15.7K	Buy	+566	New	+$25.3K	﹤0.01%	3111
2025 Q3	–	Sell	-260	Closed	-$61.8K	–	2914
2025 Q2	$61.8K	Buy	+260	New	+$50.7K	﹤0.01%	1982
2022 Q1	–	Sell	-4	Closed	-$12K	–	814
2021 Q4	$12K	Buy	+4	New	+$18.6K	0.01%	639

Other funds holding KALA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

XTX Topco's KALA Position: Q1 2026 in Review

XTX Topco sold out of KALA BIO (KALA) in Q1 2026, closing a stake of 566 shares — an estimated $15.7K sold.

XTX Topco first reported a position in KALA in Q4 2021 and held it in 3 quarters. The position peaked at $61.8K in Q2 2025. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

XTX Topco reported no remaining KALA BIO position as of Q1 2026 after selling out during the quarter.
XTX Topco sold 566 KALA BIO shares in Q1 2026, an estimated $15.7K.
XTX Topco first reported a position in KALA BIO in Q4 2021 and held it in 3 quarters.
XTX Topco's KALA BIO position peaked at $61.8K in Q2 2025.
28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.